Courts and the Federal Trade Commission should consider more than harm to competition when evaluating healthcare mergers; they should also consider the benefit to underserved communities, Phil Goldberg and Kateland Jackson of Shook, Hardy & Bacon wrote in a Bloomberg Law op-ed Feb. 9.
